Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

U.S. Markets are not yet open, but GSK is being traded in the pre-market session. Pre-Market quote »
Delayed Data
As of Aug 03
 +0.07 / +0.16%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 27 analysts offering 12-month price forecasts for GlaxoSmithKline have a median target of 46.33, with a high estimate of 56.21 and a low estimate of 37.77. The median estimate represents a +6.48% increase from the last price of 43.51.

Analyst Recommendations

The current consensus among 29 polled investment analysts is to Hold stock in GlaxoSmithKline. This rating has held steady since August, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Oct 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 17.37%
Growthannually -20.70%


Growthquarterly 3.21%
Growthannually 4.73%
Key to the earnings and sales forecast charts.